Updated Jul 16, 2026
Payne Fletcher has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Payne Fletcher is identified in SEC filings as an insider associated with Aptose Biosciences Inc. as of July 1, 2026. Public biographical information about Payne Fletcher is limited; available filings indicate an affiliation with Aptose but do not disclose a detailed professional background in widely accessible sources. The exact role, responsibilities, and career history are not publicly documented in major outlets.
| Role | Insider |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-01 | APTO | Aptose Biosciences Inc. | D — Derivative transaction | 22 | $1.72 | $38 |
| 2026-07-01 | APTO | Aptose Biosciences Inc. | D — Derivative transaction | 222 | $1.72 | $382 |
Payne Fletcher is identified in SEC filings as an insider associated with Aptose Biosciences Inc. as of July 1, 2026. Public biographical information about Payne Fletcher is limited; available filings indicate an affiliation with Aptose but do not disclose a detailed professional background in widely accessible sources. The exact role, responsibilities, and career history are n…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Payne Fletcher profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.